Clomisign 150 mg Tablet: Advanced Ovulation Inducing Fertility Therapy Extensive Product Profile: Understanding Clomisign 150 mg Clomisign 150 mg contains Clomiphene Citrate, a non-steroidal, advanced Selective Estrogen Receptor Modulator (SERM). Manufactured to strict global standards by HAB Pharmaceuticals (Signature), this high-strength variant is widely utilized under strict supervision by fertility specialists and reproductive endocrinologists to manage complex ovulatory dysfunction and support assisted reproductive technologies (ART). 1. Clinical Indications & Usage Ovulation Induction in Refractory Cases: Prescribed primarily for the treatment of ovulatory failure in women who have shown insufficient follicular response to lower starting doses (e.g., 50 mg or 100 mg). PCOS Management: Deployed as an advanced therapeutic option to stimulate robust follicular development in patients suffering from Polycystic Ovary Syndrome (PCOS) displaying resistance to initial treatment tiers. Luteal Phase Support & ART/IVF Prep: Utilized in controlled ovarian hyperstimulation protocols prior to Intrauterine Insemination (IUI) or In Vitro Fertilization (IVF) cycles. 2. Mechanism of Action: How Clomisign Works Estrogen Receptor Antagonism: It binds competitively to estrogen receptors throughout the hypothalamus and pituitary gland, blocking the negative feedback loop of endogenous estrogen. Upregulation of GnRH: By mimicking low circulating estrogen levels, the hypothalamus is triggered to increase the pulsatile secretion of Gonadotropin-Releasing Hormone (GnRH). FSH and LH Surge: Enhanced GnRH secretion prompts the anterior pituitary gland to release higher quantities of Follicle-Stimulating Hormone (FSH) and Luteal Hormone (LH). 3. Administration and Dosing Guide Administration Route: Clomisign 150 mg is an oral tablet formulation. It must be swallowed whole with a glass of water and never be chewed, crushed, split, or dissolved. Food Interactions: Tablets can be administered consistently with or without food, preferably at a fixed time each day. Standard Schedule: Therapy typically consists of a short 5-day cycle, initiated early during the menstrual phase (usually beginning on Day 3 or Day 5 of the cycle). Dosing and duration must be tailored strictly to individual ultrasound monitoring and hormone tracking responses. It is highly advised not to extend treatment beyond 3 to 6 consecutive menstrual cycles. ⚠️ Safety, Side Effects, and Monitoring Ovarian Hyperstimulation Syndrome (OHSS): Due to the increased dosage strength, close monitoring is essential to prevent OHSS, characterized by significant ovarian enlargement, fluid accumulation in the abdomen/thorax, and hemoconcentration. Immediate medical assessment is mandatory if severe abdominal pain or bloating occurs. Multiple Pregnancies: Clinical users must be counseled that ovulation induction significantly increases the probability of multiple births (primarily twins or higher-order gestations) compared to natural conception. Common Side Effects: Hot flashes, pelvic discomfort, abdominal bloating, breast tenderness, mood swings, nausea, headaches, and dizziness. 📦 Storage and Handling Specifications Storage Framework: Store Clomisign 150 mg tablets consistently below 30°C (86°F) in a dark, dry, climate-controlled pharmaceutical facility. Environmental Safeguards: Keep the tablets safely sealed inside their original moisture-resistant blister strips. Protect the shipment from high environmental humidity, ambient moisture spikes, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) Verified Batch Origin Ledger Global Import Compliance Papers PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: This profile is compiled strictly for global commercial distribution, wholesale international procurement, and educational institutional research. Clomisign 150 mg Tablet is a specialized fertility agent available exclusively upon official authorization (PRESCRIPTION MEDICINE IS YES). It must be distributed, managed, and taken under the strict surveillance of a qualified gynecologist or reproductive endocrinologist. Why Choose Ernest Impex? Traceability Regulatory Support Secure Bulk Supply 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383